Patent CA1259149A successfully refreshed from Google Patents.
Patent US4942182A successfully refreshed from Google Patents.
US4942182A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Treatment for cocaine addiction
Assignee: United States Department of Health and Human Services
•
Filing: 1989-03-01
•
Granted: 1990-07-17
•
Expires: 2009-03-01
Abstract
Abstract Chronic oral adminstration of carbamazepine may be used to block reinforcing effects and toxic effects of cocaine. It is preferred that the subject be esstentially "clean" of codeine at the time the treatment with carbamazepine is commenced.
Inventors
- 👤 Susan R. B. Weiss
- 👤 Robert M. Post
- 👤 Thomas G. Aigner
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 08:49
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/55; A61P; A61P25/00; A61P25/30
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
36 words
A method of blocking toxic effects of cocaine comprising the chronic administration of carbamazepine to a host susceptible to cocaine addiction in an amount sufficient to achieve a 4 0 12 ug/ml blood concentration of carbamazepine.
Claim 2
Independent Claim
36 words
A method of blocking toxic effects of cocaine comprising the chronic administration of carbamazepine to a host susceptible to cocaine addiction in an amount sufficient to achieve a 4 0 12 ug/ml blood concentration of carbamazepine.
Claim 3
Dependent Claim
11 words
A method of claim 1 wherein the carbamazepine is given orally.
Claim 4
Dependent Claim
14 words
A method of claim 2 wherein the dosage of carbamazepine given is 200-2000 mg/day.
Claim 5
Independent Claim
21 words
A method of blocking the reinforcing effects of cocaine by administering to a susceptible host a reinforcing-blocking effective amount of carbamazepine.
Claim 6
Independent Claim
21 words
A method of blocking the reinforcing effects of cocaine by administering to a susceptible host a reinforcing-blocking effective amount of carbamazepine.
Claim 7
Dependent Claim
18 words
A method of claim 4 wherein the carbamazepine is given by oral route in a pharmaceutically acceptable carrier.
Claim 8
Dependent Claim
14 words
A method of claim 5 wherein the dosage of carbamazepine administered is 200-2000 mg/day.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-07-16 | 1994-01-15 | 1994-07-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-07-16 | 1998-01-15 | 1998-07-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-07-16 | 2002-01-15 | 2002-07-17 | $7700.00 | Window Closed / Lapsed |